Assumptions are made based on studies in small, selected, often diseased populations.[8,9] For example, inflammation and aging are suggested to raise EPO levels[10,11], whereas diabetes lowers EPO levels.[12] Molecular regulation of EPO in hypoxia, by means of the hypoxia-inducible factors, has been well studied. This evidence concerns the gene EPO and diabetes mellitus.